All lobbying filings

HOLLAND & KNIGHT LLP

Lobbying for UNITED MITOCHONDRIAL DISEASE FOUNDATION · Non-profit organization

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 17, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.

Budget/Appropriations

FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health.

Bills named in this filing 2

H.R. 5684
Medical Foods and Formulas Access Act of 2025
S. 3304
Medical Foods and Formulas Access Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.